Clinical Trials Browser

Immunohistochemistry × CNS × Clear all

NCT01149850 2024-09-19

Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

Phase 2 Completed

Glioblastoma, Gliosarcoma

NCT06363162 2024-04-12

Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery

Phase NA Unknown

Glioma

NCT00387400 2023-08-04

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00788125 2023-07-14

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Phase 1/2 Terminated

7 enrolled 9 charts

CNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Testicular Germ Cell Tumor, Astrocytoma, Burkitt Lymphoma, Carcinoma, Renal Cell, Immunoblastic Lymphadenopathy, Kidney Neoplasms, Liver Neoplasms, Lymphoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Recurrence, Sarcoma, Osteosarcoma, Spinal Cord Neoplasms, Teratoma, Testicular Neoplasms, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Nephroma, Mesoblastic, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT00492167 2022-03-07

Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT01234740 2018-04-17

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00897663 2018-01-24

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01172964 2017-11-09

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT01004523 2016-07-18

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT01553175 2016-07-14

Studying Gene Expression in Samples From Patients With Rhabdoid Tumors

CNSGenitourinary

Kidney Neoplasms, Central Nervous System Neoplasms, Rhabdoid Tumor

NCT01493830 2016-07-11

Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma

Neuroblastoma

NCT01387724 2016-05-18

Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

Neuroblastoma

NCT01553448 2016-05-18

Studying Gene Expression in Samples From Younger Patients With Neuroblastoma

Neoplasms, Neuroblastoma

NCT01585389 2016-05-18

Studying Gene Expression and Location in Samples From Patients With Brain Tumors

Brain Neoplasms, Central Nervous System Neoplasms

NCT01358604 2016-04-15

Biomarkers in Samples From Young Patients With Neuroblastoma

Neuroblastoma

NCT00360945 2013-09-17

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Phase 2 Unknown

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00424060 2012-09-24

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma